What is the recommended initial management for a patient with acute liver failure?

Initial Management of Acute Liver Failure

Immediately admit the patient to an ICU, contact a liver transplant center early, begin N-acetylcysteine (NAC) regardless of etiology, and perform urgent etiological workup while providing aggressive supportive care. 1, 2

Immediate Actions (First Hours)

1. Admission and Early Consultation

• Admit to ICU for close monitoring 2
• Contact liver transplant center immediately when PT ratio <50% (INR typically >1.5), even before encephalopathy develops 1
• Transfer should be arranged early in evaluation, not delayed until deterioration 2

2. Start N-Acetylcysteine Immediately

Administer NAC to ALL patients with acute liver failure, regardless of suspected etiology 1

• For acetaminophen toxicity: Strong evidence shows reduced mortality (0.7% vs 6%) and hepatotoxicity (18% vs 58%) 1
• For non-acetaminophen ALF: Meta-analysis demonstrates improved overall survival (76% vs 59%) and transplant-free survival (64% vs 26%) 1
• Most effective when started early, particularly in grades I-II encephalopathy 1

Dosing regimens:

• IV route (preferred in ALF): 150 mg/kg loading dose over 15 minutes, then 50 mg/kg over 4 hours, then 100 mg/kg over 16 hours 2
• Oral route: 140 mg/kg loading dose, then 70 mg/kg every 4 hours for 17 doses 2

3. Essential Diagnostic Workup

Perform immediately 1:

Blood tests:

• Serum acetaminophen level (even without history—very high transaminases >3,500 IU/L suggest acetaminophen) 2
• Hepatitis A IgM, Hepatitis B surface antigen (HBsAg) and anti-HBc IgM 1
• Urinary toxicology screen (amphetamines, cocaine) 1
• PT/INR, Factor V level 1
• Blood glucose (monitor every 2 hours) 1
• Arterial blood gas, lactate, arterial ammonia 1

Imaging:

• Hepatic Doppler ultrasound (assess vascular patency, exclude Budd-Chiari) 1
• Echocardiography (assess cardiac function, exclude ischemic hepatitis) 1

Etiology-Specific Treatments

Acetaminophen Toxicity

• If presentation within 4 hours: give activated charcoal (1 g/kg) just before NAC 2
• Continue NAC even if >48 hours post-ingestion 2

Herpes Simplex Virus (Suspected)

• Start acyclovir immediately if fever present or HSV suspected 1
• Consider in immunosuppressed patients, pregnant women (especially third trimester), or those with unexplained ALF 2
• List for transplantation urgently 2

Hepatitis B

• Consider nucleoside analogues (lamivudine or adefovir), though evidence limited in acute setting 2

Autoimmune Hepatitis

• Start prednisone 40-60 mg/day if suspected 2
• Consider liver biopsy if diagnosis uncertain (look for interface hepatitis, plasma cells, rosettes) 2
• List for transplantation even while treating 2

Wilson Disease

• Suspect if: young patient, hemolytic anemia, bilirubin >20 mg/dL, very low alkaline phosphatase, bilirubin/alkaline phosphatase ratio >2.0 2
• Do NOT use penicillamine in acute setting (hypersensitivity risk) 2
• Use plasmapheresis, plasma exchange, or continuous hemofiltration for acute copper lowering 2
• List for urgent transplantation (uniformly fatal without transplant) 2

Mushroom Poisoning (Amanita)

• Penicillin G: 300,000-1 million units/kg/day IV 2
• Silymarin/silibinin: 30-40 mg/kg/day (more effective than penicillin but not FDA-approved in US) 2
• Consider NAC as adjunct 2
• List for transplantation early 2

Pregnancy-Related (Third Trimester)

• Acute fatty liver of pregnancy or HELLP syndrome: expeditious delivery is treatment 2
• Also consider HSV hepatitis (treat with acyclovir) 2

Critical Supportive Care

Hemodynamic Management 3, 1

• Crystalloids as first-line fluid resuscitation
• Norepinephrine as first-line vasopressor for persistent hypotension
• Add vasopressin if hypotension persists despite norepinephrine

Neurological Management 1

• Monitor encephalopathy grade frequently
• Maintain serum sodium 140-145 mmol/L
• Intubate if Glasgow Coma Scale <8 or progressive encephalopathy
• Use hypertonic saline or mannitol for intracranial pressure elevations 3
• Avoid: benzodiazepines, metoclopramide, lactulose, rifaximin 1

Metabolic Management 1

• Monitor glucose every 2 hours, correct hypoglycemia aggressively
• Avoid hyperglycemia

Renal Management 3

• Early CRRT initiation for persistent hyperammonemia, hyperkalemia, or metabolic abnormalities

Coagulation 1

• Do NOT routinely correct coagulopathy
• Transfuse only for active bleeding or before invasive procedures
• Hemoglobin target: 7 g/dL 3
• Consider VTE prophylaxis daily 3

Infection Prevention 3

• Prophylactic antibiotics are weakly recommended
• Empirical broad-spectrum antibiotics if worsening encephalopathy or SIRS 1

Nutrition 3

• Enteral nutrition preferred over parenteral (if no contraindications)

Transplant Evaluation

Criteria for listing 1, 4:

• MELD score ≥30.5 (preferred over King's College Criteria—more sensitive) 4
• Development of grade 3-4 hepatic encephalopathy (transplant-free survival only 33%) 1
• Severe ALF with PT ratio <50% warrants transplant center discussion 1

Common Pitfalls

1. Delaying transplant center contact: Contact when PT ratio <50%, not when encephalopathy develops 1
2. Withholding NAC in non-acetaminophen cases: Evidence supports use in all etiologies 1
3. Routinely correcting coagulopathy: Increases bleeding risk and obscures prognostic markers 1
4. Using lactulose or rifaximin: No evidence in ALF, may worsen encephalopathy 1
5. Missing acetaminophen toxicity: Check levels in all patients; very high transaminases (>3,500 IU/L) suggest acetaminophen even without history 2
6. Starting penicillamine for Wilson disease: Use plasma exchange instead 2